Highlights
NASDAQ: CLBS       Caladrius Bio
Last Price Today's Change   Day's Range   Trading Volume
2.95   +0.04 (1.37%)  2.90 - 3.03  3,259

Overview

 
Avg Volume (4 weeks):37,833
4 Weeks Range:2.41 - 3.64
4 Weeks Price Volatility (%):
43.90%
52 Weeks Range:2.00 - 5.44
52 Weeks Price Volatility (%):
27.62%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Caladrius Biosciences Inc is a company developing cellular therapeutics to treat certain diseases. The company has internal specialized cell therapy clinical development expertise to select and develop early-stage cell therapy candidates with the intention of partnering these candidates post proof-of-concept in humans. The product portfolio pf the group includes, CLBS03, an ex vivo expanded polyclonal T regulatory cell therapy for the treatment of recent-onset type 1 diabetes in a enrolling Phase 2 trial.

  Be the first to like this.
 


 

3262  2360  421  2919 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 ACHN 6.760.00 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 PFE 38.495-1.665 
 ECA 3.79-0.25 
 F 8.94+0.05 
 NIO 4.165+0.155 
 VXRT 0.885+0.243 
Partners & Brokers